跳至主要内容
临床试验/NCT02955563
NCT02955563已完成不适用

CSDM: A Trial to Improve Communication and Shared Decision Making Using a Web-Based Tool

University of Pittsburgh2 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2017年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
2
主要终点
Intervention compliance

研究概览

简要总结

The goal is to develop a pragmatic, scalable intervention to overcome problems with surrogate decision making in ICUs.

The aim is to conduct a pilot study among surrogates and clinicians of 50 incapacitated patients at high risk of death to assess the feasibility of deploying the web-based tool as well as to examine the tools impact on the patient and family outcome measures summarized in the hypotheses below.

详细描述

Roughly 600,000 Americans annually die in or shortly after an ICU admission, generally after decisions by surrogates to forego life support. Several decades of research indicate:

  1. Family members in ICUs often struggle in the role of surrogate and experience high rates of lasting psychological sequelae (e.g. depression, anxiety, PTSD). For example, a systematic review found that one third of surrogates have long term feelings of guilt and doubt about the decisions they made.
  2. Patients often receive treatment that is inconsistent with their values and preferences. For example, in the SUPPORT trial, physicians were frequently unaware of patients' wishes regarding end-of-life care, and patients often died receiving more invasive treatment than they preferred.
  3. Intensive care near the end of life is a significant contributor to health care costs. For example, medical care in the last year of life accounts for 25% of Medicare costs, and ICU care contributes substantially.

Breakdowns in clinician-family communication in ICUs are common and an important target for interventions. Using quantitative analysis of audiorecorded goals of care discussions in ICUs, we found that in more than 50% of conversations clinicians did not inquire about the patient's values and treatment preferences, and in a similar proportion failed to explicitly offer alternatives to indefinite life-prolonging treatment, such as time-limited trials or comfort-focused treatment. We have also documented frequent omissions of important prognostic information during such conversations and other researchers have documented that surrogates often hold unduly optimistic estimates of patients' prognosis. These data highlight the importance of improving the quality of collaborative decision making in ICUs.

This proposal is responsive to national research priorities: The proposed research addresses priority areas for national action from the Institute of Medicine and NIH: improving clinician-family communication and end-of-life care for patients with advanced organ system failure. It is responsive to calls by the Institute on Aging to promote patient-centered decision making for elderly patients.

A critical barrier to addressing these problems is the absence of a scalable intervention. No empirically validated decision support tools exist for the range of critical illnesses confronted in ICUs. Prior interventions to address these problems (e.g., proactive palliative care consultation or adding a family support counselor to the ICU team) face major barriers to dissemination due to projected palliative care workforce shortages and the high cost of adding more personnel to ICU care teams.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Surrogate decision maker for ICU patient that lacks decisional capacity
  • Permission from Patient's ICU Primary Attending Physician

排除标准

  • Non-English Speaking
  • Inability to read or write

研究组 & 干预措施

CSDM Tool

Experimental

Surrogate will complete educational sessions on CSDM tool prior to each family meeting with clinical team.

干预措施: CSDM Web-Based Tool Intervention (Other)

Control

No Intervention

Surrogates will receive augmented usual care. The augmentation is that there will be 2 family meetings scheduled during the first 10 days of enrollment.

结局指标

主要结局

Intervention compliance

时间窗: Duration of ICU stay, an expected average of 4 weeks

Data tracking analytics will be employed to determine the extent to which the tool is used as per protocol.

次要结局

  • Participants' ratings of perceived usefulness of the tool(Duration of hospital stay, an expected average of 4 weeks)
  • Participants' ratings of usability of the tool(Duration of hospital stay, an expected average of 4 weeks)
  • Participants' ratings of acceptability of the tool(Duration of hospital stay, an expected average of 4 weeks)
  • Feasibility of enrolling family members in a critical care setting(Through study completion, estimate one year past primary start date)
  • Feasibility of retaining family members in a critical care setting in a trial(Three months post-discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Douglas White

Vice Chair and Professor of Critical Care Medicine

University of Pittsburgh

研究点 (2)

Loading locations...

相似试验